Patient-Friendly Explanation

Retinol-binding protein 4 is a protein released by fat cells and the liver that carries vitamin A through the blood. Higher levels are seen in people with more fat around the organs and poorer response to insulin, and levels often fall after meaningful weight loss.

Clinical Definition

RBP4 is a 21-kDa lipocalin secreted by adipocytes and hepatocytes that transports retinol bound to transthyretin. Elevated serum RBP4 impairs insulin signalling in skeletal muscle and liver, partly through retinol-dependent STRA6 signalling, and is associated with visceral adiposity, impaired glucose tolerance and metabolic dysfunction-associated steatotic liver disease. Interpretation must account for kidney function, since RBP4 rises in chronic kidney disease, and for retinol and retinol-binding status.

Why It Matters

RBP4 is one of the adipokines that links fat distribution, not just fat amount, to metabolic risk, so two patients at the same weight can have very different insulin sensitivity. NuLifeCare Singapore interprets these markers together with waist circumference and renal function before drawing conclusions about metabolic improvement.